Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis
Susanne A. Snoek(Amsterdam UMC Location University of Amsterdam), Wouter J. de Jonge(University of Bonn), Michael J. Skynner(GlaxoSmithKline (United Kingdom)), Marleen I. Verstege, Guy E. Boeckxstaens(KU Leuven), Nigel Deeks(GlaxoSmithKline (United Kingdom)), David C. Bulmer(Queen Mary University of London), Anje A. te Velde(Amsterdam University Medical Centers), Kevin Lee(GlaxoSmithKline (United Kingdom)), Esmerij P. van der Zanden(Amsterdam UMC Location University of Amsterdam)
Cited by 83
Related Papers
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment
|Nature Neuroscience|2019|1.1k
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
|Nature Immunology|2005|1.1k
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia
|New England Journal of Medicine|2011|852
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
|British Journal of Pharmacology|2007|634